Xvivo Perfusion AB (publ) (STO:XVIVO)

Market Cap	9.39B
Revenue (ttm)	854.98M
Net Income (ttm)	137.00M
Shares Out	31.50M
EPS (ttm)	4.33
PE Ratio	68.90
Forward PE	48.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,856
Average Volume	72,091
Open	295.60
Previous Close	301.80
Day's Range	294.40 - 300.60
52-Week Range	238.20 - 547.00
Beta	1.92
RSI	42.61
Earnings Date	Jul 11, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 190
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: XVIVO

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.